News

Understanding Market Sentiment for Recursion Pharmaceuticals

Understanding Market Sentiment for Recursion Pharmaceuticals

Market Sentiment Towards Recursion Pharmaceuticals

Investors who possess significant resources have adopted a bearish outlook on Recursion Pharmaceuticals (NASDAQ: RXRX). This sentiment is crucial for retail traders to observe as it can influence market dynamics.

Recent Trading Activity

Today, tracking the options history revealed notable positions that raised eyebrows and signaled potential market movements related to RXRX. Amid substantial trades that were recorded, it is evident that when such significant activity occurs, it often indicates that some investors may anticipate upcoming developments.

Insights on Options Trades

Today's analysis unveiled 14 trades within the options market tied to Recursion Pharmaceuticals. A stark observation here is that these trades are unusual, suggesting that larger players in the market are taking a keen interest in the stock. An insight into the sentiment indicates that approximately 28% are bullish, while a larger 35% lean bearish.

Breakdown of Options Activity

From all of the trades discovered, there was a single put option totaling $28,225 while the remaining 13 calls amounted to $916,047, highlighting a decisively aggressive betting trend on the calls.

Expected Price Movements

Delving deeper into the trading behavior, it shows that major investors have their eyes on price movements within the $3.0 to $17.0 range for Recursion Pharmaceuticals over the recent months.

Volume and Open Interest Analysis

Evaluating volume and open interest is an essential strategy when engaging in options trading. This analysis reveals important insights into the liquidity and enthusiasm among investors toward the options associated with RXRX, particularly in specified strike prices within a $3.0 to $17.0 range over the last 30 days.

Recent Option Volume Statistics

The snapshot reflects the significant trades correlated with the option side of Recursion Pharmaceuticals. The fluctuations in volume and open interest affirm notable trading levels for both call and put options.

Biggest Options Activities Reported

Symbol   | PUT/CALL | Trade Type | Sentiment  | Exp. Date    | Ask   | Bid   | Price  | Strike Price | Total Trade Price | Open Interest | Volume
-------- | -------- | -----------| ---------  | ------------ | ----- | ----- | ------ | --------------| ----------------- | ------------- | ------
RXRX     | CALL    | SWEEP      | NEUTRAL    | 07/25/25     | $0.45 | $0.40 | $0.40  | $6.50        | $182.4K          | 1.8K         | 5.0K 
RXRX     | CALL    | SWEEP      | BEARISH    | 09/19/25     | $0.50 | $0.45 | $0.45  | $10.00       | $180.0K          | 3.7K         | 5.1K
RXRX     | CALL    | SWEEP      | NEUTRAL    | 09/19/25     | $1.65 | $1.55 | $1.60  | $6.00        | $163.8K          | 11.9K        | 2.3K
RXRX     | CALL    | SWEEP      | BULLISH    | 07/25/25     | $0.85 | $0.75 | $0.80  | $6.00        | $56.3K           | 15.2K        | 2.8K
RXRX     | CALL    | TRADE      | NEUTRAL    | 07/25/25     | $1.15 | $1.05 | $1.10  | $6.00        | $55.0K           | 15.2K        | 9.7K

Profile of Recursion Pharmaceuticals

Recursion Pharmaceuticals Inc is recognized for its pioneering approach in biotechnology. The company intricately blends technology across biological sciences, chemistry, automation, and engineering to revolutionize drug discovery and ultimately enhance patient outcomes significantly.

Current Trading Position

  • Presently, RXRX is trading at a vibrant volume of 65,934,254 with its price reflecting a substantial increase of 11.62%, now resting at $6.52.
  • Relative strength indicators suggest the stock might be nearing overbought territory.
  • All eyes are on the anticipated earnings release set for the near future.

Expert Ratings on Recursion Pharmaceuticals

In the previous month, two financial experts provided ratings for RXRX with an average target price set at $6.50. Notably, while some analysts are optimistic, others have taken a more cautious stance. An analyst downgraded the view to 'Buy' with a set target price of $8, while another reduced it to 'Equal-Weight' with a target of $5.

The Nature of Options Trading

Engaging in options trading represents a more complex financial strategy compared to standard stock trading, but it holds the potential for higher profits. Successful options traders manage risks by continuously educating themselves, employing a variety of indicators, and maintaining a close watch on market movements.

Keep Informed on Recursion Pharmaceuticals

For those eager to remain at the forefront of options trades pertaining to Recursion Pharmaceuticals, tools available provide essential real-time alerts, guiding investors towards informed trading decisions.

Frequently Asked Questions

What is the current stock price of Recursion Pharmaceuticals?

The current stock price is noted to be $6.52.

What does significant options trading indicate?

It often suggests that larger investors are anticipating key developments that may affect the stock's performance.

Where can investors find updates on options trading?

Real-time updates can be accessed through various trading platforms.

What are the expected price ranges for RXRX?

Investors are eyeing a price territory between $3.0 and $17.0 over the recent months.

Who monitors the options trading for Recursion Pharmaceuticals?

Financial analysts and tracking tools continually monitor these activities to provide insights to traders.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 139

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
Revolutionary Sports Ball Backpack: A Game Changer?

Updated Category News Views 59

Backpacks Reinvented by a Clever Mom Ever been caught in the whirlwind of juggling kids, sports gear, and school supplies? Well, one stay-at-home mom from Poway, California found herself in just such a predicament. She turned this everyday chaos into a creative solution by designing a unique Sports Ball Backpack. The idea came to her while managing a toddler, a newborn,...

Continue Reading
Duke Energy's Cooling Tips Amid Florida Cold Front

Updated Category News Views 205

Weather Whiplash in Florida Prompts Energy Tips Florida's residents are in for a gust of chilly air as a cold front sweeps across the state, sending temperatures plummeting from the balmy 80s to brisk 30s and 40s in northern pockets. Central Florida ain't missing out on the chill either, expecting to dip a good dozen degrees below its usual seasonal warmth. Heads up,...

Continue Reading
Shorenstein Expands in Dallas: Strategic Play or Risk?

Updated Category News Views 80

Shorenstein's recent acquisition of International Plaza 3 isn't just about adding another high-rise to their portfolio; it's a stake in the ground, a doubling down on the Dallas real estate market. With its aim sharply set on the Lower Tollway submarket, Shorenstein is showing confidence, but the big question remains—are they spot on or walking the razor's edge?...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 117

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
LEOTEK's AI Tech Shaping Smarter Cities at COP31

Updated Category News Views 103

AI-Powered Evolution in Urban Infrastructure Hang on to your hats, folks, 'cause LEOTEK is turning heads at COP31 with its AI-driven transformation of urban landscapes. As cities stretch at the seams to keep up with modern challenges, LEOTEK's got more than a few tricks up its sleeve with its trademark blend of traffic system intelligence and energy management prowess....

Continue Reading
Matthew Callstrom Named CEO: Mayo Clinic's Next Era

Updated Category News Views 129

Leadership Change at Mayo Clinic: A Turning Point The Mayo Clinic, a titan in healthcare lands, is on the cusp of a major leadership switch-up. As the trustees hand the reins to Dr. Matthew R. Callstrom, they're banking on a rich blend of experience and visionary thinking to steer their ship. We're looking at what this change might spell for Mayo's storied mission. Who is...

Continue Reading
YYForce Expands in UAE with Key Hospitality Wins

Updated Category News Views 170

Unveiling YYForce's Middle East Strategy Smack in the middle of an aggressive Middle Eastern expansion, YYForce (NASDAQ: YFOR) is making waves with some new headline-grabbing contracts in the UAE. This ain't just a side hustle—it's big time. They're planting their flag across the luxury hospitality sector like they're going for a moon landing. The recent announcement...

Continue Reading
SPOC Energy's Hiring Push Signals Growth Surge

Updated Category News Views 64

A Growing Workforce for a Growing Demand Here we are, smack dab in a bustling week of business news, and among it, SPOC Energy is ramping up its workforce across Alabama. Now, SPOC isn't any run-of-the-mill operation; this Birmingham-based manufacturer messes around with advanced power conversion systems and motor-control automation—a mouthful, sure, but critical stuff...

Continue Reading
Winterproofing Your Home: Simple Tips to Save Money

Updated Category News Views 63

Winter Is Coming: Time to Prep Your Home When it’s cold enough to freeze a dog's nose, the last place you want a surprise is in your own cozy corner of the world. Quality Heating, Cooling, Plumbing & Electric, the whiz-kids from Glenpool, Oklahoma, are out with some pointers for keeping your house peachy all through winter's tests. We’re talking ways to dodge frozen...

Continue Reading

Top 5 Most Recently Viewed Articles

Cody vs. Yellowstone Lodging: A Travel Base Analysis

Updated Category News Views 26

Choosing a Basecamp for Your Yellowstone Adventure When it comes to plotting out where to stay for a trip to Yellowstone National Park, let me lay it down plain for you: options abound, but they aren't all built alike. Our spotlight today? Cody, Wyoming—a town that's more than just a stepping stone. This place is gunning to be your go-to Yellowstone travel base, and...

Continue Reading
Kaiser Permanente Settles Whistleblower Case for $556 Million

Updated Category News Views 254

Kaiser Permanente Settles for $556 Million Kaiser Permanente has reached a landmark settlement, agreeing to pay $556 million to resolve allegations related to improper Medicare Advantage risk-adjustment practices. This settlement, noted by the U.S. Department of Justice, is significant as it represents the largest recovery in a whistleblower case of this nature to date....

Continue Reading
Urgent Call for Blood Donations Amidst Winter Challenges

Updated Category News Views 115

Blood Donation Needs Urgent Attention Officials are raising awareness about the significant blood shortages caused by recent winter storms and rising illnesses, such as norovirus. The Versiti Blood Center of Michigan has launched an urgent appeal for blood donations, stressing that the drastic weather conditions have severely impacted donations. Hospitals are now facing...

Continue Reading
Safe and Green Development Corp Announces Exciting Stock Dividend

Updated Category News Views 120

Safe and Green Development Corporation Declares Stock Dividend Safe and Green Development Corporation (NASDAQ: SGD) has taken an exciting step forward by announcing a stock dividend that reflects its commitment to shareholders. The Company has declared a stock dividend of 0.05 shares of common stock for every outstanding share held. This means for every 20 shares owned,...

Continue Reading
LRS Healthcare Expands Leadership With New Executive Team Members

Updated Category News Views 217

LRS Healthcare Expands Leadership With New Executive Team Members LRS Healthcare, a prominent player in the healthcare staffing industry, is making significant strides with the recent addition of Travis Powers and Tracey Duke to its executive team. This move is poised to enhance the company's leadership capabilities and foster growth within the organization. Introducing...

Continue Reading